Middle East respiratory syndrome coronavirus infection CT

Middle East Respiratory Syndrome Coronavirus Infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Other Diagnostic Studies
Treatment
Medical Therapy
Contact and Airborne Precautions
Primary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Middle East respiratory syndrome coronavirus infection CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Middle East respiratory syndrome coronavirus infection CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Middle East respiratory syndrome coronavirus infection CT
CDC on Middle East respiratory syndrome coronavirus infection CT
Middle East respiratory syndrome coronavirus infection CT in the news
Blogs on Middle East respiratory syndrome coronavirus infection CT
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection
Risk calculators and risk factors for Middle East respiratory syndrome coronavirus infection CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Middle East Respiratory Syndrome (MERS) is a viral respiratory illness. It is caused by an emerging coronavirus, specifically a betacoronavirus called MERS-CoV (Middle East Respiratory Syndrome Coronavirus), first discovered in 2012. Being a relatively novel virus, there is no virus-specific prevention or treatment options for MERS patients. Attending to the fact that a vaccine hasn't been developed yet, enhancing infection prevention and control measures is critical to prevent the possible spread of MERS-CoV in hospitals and communities. Persons with symptoms suspicious of MERS-CoV infection need medical evaluation. According to the CDC: a confirmed case of MERS-CoV infection is considered an individual who shows laboratory confirmation of infection by MERS-CoV. This last one is given by a positive PCR test of ≥2 specific genomic targets or, a single positive target followed by successful sequencing of a second. Aprobable case of MERS-CoV infection is an individual who has missing or inconclusive laboratory test results for the infection and that has been in close contact with another individual who is a "laboratory-confirmed case" of MERS-CoV infection.